IQVIA™ Real-World Insights Bibliography

Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning ? Based on the ARCTIC Study
Author(s): Björn Ställberg 1, Karin Lisspers 1, Kjell Larsson 2, Christer Janson 3, Mario Müller 4, Mateusz Łuczko 5, Bine Kjøller Bjerregaard 6, Gerald Bacher 7, Björn Holzhauer 7, Pankaj Goyal 7, Gunnar Johansson 1
Affiliations(s): 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden. 3Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 4Department of Data Science and Advanced Analytics, IQVIA, Frankfurt Am Main, Germany. 5Department of Data Science and Advanced Analytics, IQVIA, Warsaw, Poland. 6Department of Real World Evidence Solutions, IQVIA, Copenhagen, Denmark. 7Department of Clinical Development and Analytics, Novartis Pharma AG, Basel, Switzerland.
Publication(s):  Journal: Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:677-688. doi: 10.2147/COPD.S293099. eCollection 2021. Conference: IPCRG, Dublin, Ireland, Weekly series of Clinical Practice Webinars - Various Saturdays from 16th May to 27th June 2020
PMID: 33758504 PMCID: PMC7981164 DOI: 10.2147/COPD.S293099
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Epidemiological study, Population Based Study,
  Add to report
 
 
SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
Author(s): Christina D. Mack; John DiFiori; Caroline G. Tai; Kristin Y. Shiue; Yonatan H. Grad; Deverick J. Anderson; David D. Ho; Leroy Sims; Christopher LeMay; Jimmie Mancell; Lisa L Maragakis
Affiliations(s): 1 IQVIA, Durham, NC, USA (Mack, Tai, Shiue) 2 Hospital for Special Surgery (DiFiori) 3 National Basketball Association, New York, New York (DiFiori, Sims, LeMay) 4 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Grad) 5 Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina (Anderson) 6 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York (Ho) 7 Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee(Mancell) 8 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (Maragakis)
Publication(s):  JAMA Intern Med. Published online April 22, 2021. doi:10.1001/jamainternmed.2021.2114
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium. 2R&D China, AstraZeneca R&D, Shanghai, China. 3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo. #Contributed equally.
Publication(s):  BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
Document Type(s): Article,
Countries: Belgium, China,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients? data using machine learning - based on the ARCTIC study Respiratory Medicine
Author(s): Karin Lisspers a,*, Bj¨orn St¨allberg a, Kjell Larsson b, Christer Janson c, Mario Müller d, Mateusz Łuczko e, Bine Kjøller Bjerregaard f, Gerald Bacher g, Bj¨orn Holzhauer g, Pankaj Goyal g, Gunnar Johansson a
Affiliations(s): a Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden b Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden c Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden d IQVIA, Frankfurt am Main, Germany e IQVIA, Warsaw, Poland f IQVIA, Copenhagen, Denmark g Novartis Pharma AG, Basel, Switzerland
Publication(s): 
Document Type(s): 
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Predictive analytics,
  Add to report
 
 
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis
Author(s): Lavorini F, Bianco A, Blasi F, Braido F, Corsico AG, Di Marco F, Gentile A, Paggiaro PL, Pegoraro V, Pelaia G, Rogliani P, Santus P, Scichilone N, Soldi A, Canonica GW
Affiliations(s): Lavorini F: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy.
Publication(s):  Respir Med. 2020;166:105937. doi:10.1016/j.rmed.2020.105937
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Respiratory disease,
2020
  L:
A:
English
Retrospective database analysis, Survey research,
  Add to report
 
 
Predicting hospitalization of Swedish patients due to COPD exacerbation with machine learning
Author(s): Karin Lisspers, Uppsala University Christer Janson, Uppsala University Gunnar Johansson, Uppsala University Kjell Larsson, Karolinska Institutet Björn Ställberg, Uppsala University Mario Mueller, IQVIA Mateusz Luczko, IQVIA Bine Kjoeller Bjerregaard, IQVIA Stuart Fell, IQVIA Gerald Bacher, Novartis Bjorn Holzhauer, Novartis Pankaj Goyal, Novartis Pharma AG
Affiliations(s): Uppsala University, IQVIA Denmark, IQVIA Germany, IQVIA Poland
Publication(s):  IPCRG, International Primary Care Respiratory Group Conference 2020
Document Type(s): Oral presentation,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2020
  L:
A:
English
  Add to report
 
 
Osteoporosis and fracture risk associated with ICS use among Swedish COPD patients: the ARCTIC study
Author(s): Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Florian S. Gutzwiller, Karen Mezzi, Linda Mindeholm, Bine Kjoeller Bjerregaard, Leif Jorgensen, Kjell Larsson
Affiliations(s): 1Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Institutes for Biomedical Research (NIBR), Cambridge, USA and Basel, Switzerland; 5IQVIA Solutions, Copenhagen, Denmark; 6Intergrative Toxicology, National Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
Publication(s):  Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.00515-2020).
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2020
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
Author(s): Björn Ställberg 1✉, Christer Janson2, Karin Lisspers1, Gunnar Johansson1, Florian S. Gutzwiller 3, Karen Mezzi3, Bine Kjoeller Bjerregaard 4, Anne Mette Tranberg Kejs4, Leif Jorgensen4 and Kjell Larsson5
Affiliations(s): 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 3Novartis Pharma AG, Basel, Switzerland. 4IQVIA Solutions, Copenhagen, Denmark. 5Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. ?email: b.stallberg@telia.com
Publication(s):  npj Primary Care Respiratory Medicine (2020) 30:47 ; https://doi.org/10.1038/s41533-020-00207-7
Document Type(s): Article,
Countries: Sweden,
C:
Y:
Respiratory disease,
2020
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
The cost-effectiveness of physical activity in the management of COPD patients in the UK
Author(s): Ramos M1, Lamotte M1, Gerlier L1, Svangren P2, Miquel-Cases A3, Haughney J4
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 Core Respiratory, Global Product and Portfolio Strategy - Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Mölndal, Sweden 3 Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge, UK 4 Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Publication(s):  Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239
Document Type(s): Article,
Countries: Scotland,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2019
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals
Author(s): Zylbersztejn A, Standing J, De Stavola B, Hardelid P
Affiliations(s): IQVIA
Publication(s): 
Document Type(s): Abstract, Poster,
Countries: UK,
C:
Y:
Respiratory disease,
2019
  L:
A:
English
  Add to report
 
 
 1 of 25 Next Page Last Page